Want to see AU:EZZ full AI Analyst Report?
Total Valuation
EZZ Life Science Holdings Ltd. has a market cap or net worth of AU$23.52M. The enterprise value is AU$7.93.
Market CapAU$23.52M
Enterprise ValueAU$7.93
Share Statistics
EZZ Life Science Holdings Ltd. has 47,043,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding47,043,200
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
EZZ Life Science Holdings Ltd.’s return on equity (ROE) is -0.22 and return on invested capital (ROIC) is -21.93%.
Return on Equity (ROE)-0.22
Return on Assets (ROA)-0.19
Return on Invested Capital (ROIC)-21.93%
Return on Capital Employed (ROCE)-0.27
Revenue Per Employee4.21M
Profits Per Employee-483.96K
Employee Count11
Asset Turnover1.67
Inventory Turnover5.10
Valuation Ratios
The current PE Ratio of EZZ Life Science Holdings Ltd. is ―. EZZ Life Science Holdings Ltd.’s PEG ratio is 0.02.
PE Ratio―
PS Ratio0.37
PB Ratio0.70
Price to Fair Value0.70
Price to FCF-1.95
Price to Operating Cash Flow-2.68
PEG Ratio0.02
Income Statement
In the last 12 months, EZZ Life Science Holdings Ltd. had revenue of 46.28M and earned -5.32M in profits. Earnings per share was -0.11.
Revenue46.28M
Gross Profit25.77M
Operating Income-6.61M
Pretax Income-6.41M
Net Income-5.32M
EBITDA43.88M
Earnings Per Share (EPS)-0.11
Cash Flow
In the last 12 months, operating cash flow was -8.76M and capital expenditures -29.70K, giving a free cash flow of -8.79M billion.
Operating Cash Flow-8.76M
Free Cash Flow-8.79M
Free Cash Flow per Share-0.19
Dividends & Yields
EZZ Life Science Holdings Ltd. pays an annual dividend of AU$0.02, resulting in a dividend yield of 8.03%
Dividend Per ShareAU$0.02
Dividend Yield8.03%
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.05
52-Week Price Change-76.86%
50-Day Moving Average0.48
200-Day Moving Average1.00
Relative Strength Index (RSI)48.52
Average Volume (3m)14.76K
Important Dates
EZZ Life Science Holdings Ltd. upcoming earnings date is Mar 1, 2027, Before Open (Confirmed).
Last Earnings DateAug 31, 2026
Next Earnings DateMar 1, 2027
Ex-Dividend Date―
Financial Position
EZZ Life Science Holdings Ltd. as a current ratio of 8.70, with Debt / Equity ratio of 1.95%
Current Ratio8.70
Quick Ratio7.35
Debt to Market Cap0.02
Net Debt to EBITDA-0.21
Interest Coverage Ratio-381.81
Taxes
In the past 12 months, EZZ Life Science Holdings Ltd. has paid -1.09M in taxes.
Income Tax-1.09M
Effective Tax Rate0.17
Enterprise Valuation
EZZ Life Science Holdings Ltd. EV to EBITDA ratio is 0.18, with an EV/FCF ratio of -0.90.
EV to Sales0.17
EV to EBITDA0.18
EV to Free Cash Flow-0.90
EV to Operating Cash Flow-0.90
Balance Sheet
EZZ Life Science Holdings Ltd. has AU$9.72M in cash and marketable securities with AU$478.59K in debt, giving a net cash position of AU$9.25M billion.
Cash & Marketable SecuritiesAU$9.72M
Total DebtAU$478.59K
Net CashAU$9.25M
Net Cash Per ShareAU$0.20
Tangible Book Value Per ShareAU$0.52
Margins
Gross margin is 55.68%, with operating margin of -14.28%, and net profit margin of -11.50%.
Gross Margin55.68%
Operating Margin-14.28%
Pretax Margin-13.86%
Net Profit Margin-11.50%
EBITDA Margin94.82%
EBIT Margin-14.28%
Analyst Forecast
The average price target for EZZ Life Science Holdings Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-30.79%
EPS Growth Forecast-177.68%